|
Long-term incentive compensation and shareholders' equity (Tables)
|
12 Months Ended |
|
Dec. 31, 2014
|
| Share Based Compensation [Abstract] |
|
| Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements |
A combined summary of the status of the Company’s stock-settled awards under the 2011 Plan, including base shares for stock-settled stock appreciation rights and stock-settled stock unit awards is as follows:
|
|
|
Year ended December 31, 2014 |
|
|
|
|
Stock appreciation rights |
|
|
Stock units |
|
|
|
|
|
|
|
|
Weighted |
|
|
Weighted |
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
average |
|
|
average |
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
|
exercise |
|
|
remaining |
|
|
|
|
|
|
remaining |
|
|
|
|
Awards |
|
|
price |
|
|
contractual life |
|
|
Awards |
|
|
contractual life |
|
|
Outstanding at beginning of year |
|
|
12,956,094 |
|
|
$ |
45.44 |
|
|
|
|
|
|
|
966,596 |
|
|
|
|
|
|
Granted |
|
|
1,553,829 |
|
|
|
70.15 |
|
|
|
|
|
|
|
332,007 |
|
|
|
|
|
|
Exercised |
|
|
(3,473,804 |
) |
|
|
32.05 |
|
|
|
|
|
|
|
(303,970 |
) |
|
|
|
|
|
Cancelled |
|
|
(450,947 |
) |
|
|
51.49 |
|
|
|
|
|
|
|
(72,735 |
) |
|
|
|
|
|
Outstanding at end of period |
|
|
10,585,172 |
|
|
$ |
53.21 |
|
|
|
2.7 |
|
|
|
921,898 |
|
|
|
1.5 |
|
|
Exercisable at end of period |
|
|
2,541,397 |
|
|
$ |
42.79 |
|
|
|
1.6 |
|
|
|
496 |
|
|
|
0.3 |
|
|
Weighted-average fair value of grants in 2014 |
|
$ |
16.41 |
|
|
|
|
|
|
|
|
|
|
$ |
72.24 |
|
|
|
|
|
|
Weighted-average fair value of grants in 2013 |
|
$ |
13.47 |
|
|
|
|
|
|
|
|
|
|
$ |
58.90 |
|
|
|
|
|
|
Weighted-average fair value of grants in 2012 |
|
$ |
11.28 |
|
|
|
|
|
|
|
|
|
|
$ |
54.85 |
|
|
|
|
|
|
| Summary of Range of Exercise Prices |
|
|
|
Awards |
|
|
Weighted average |
|
|
Awards |
|
|
Weighted average |
|
|
Range of SSAR base prices |
|
outstanding |
|
|
exercise price |
|
|
exercisable |
|
|
exercise price |
|
|
$20.01–$30.00 |
|
|
9,000 |
|
|
|
29.90 |
|
|
|
9,000 |
|
|
|
29.90 |
|
|
$30.01–$40.00 |
|
|
893,976 |
|
|
|
34.92 |
|
|
|
710,869 |
|
|
|
34.65 |
|
|
$40.01–$50.00 |
|
|
3,230,512 |
|
|
|
43.02 |
|
|
|
1,545,204 |
|
|
|
42.86 |
|
|
$50.01–$60.00 |
|
|
4,577,354 |
|
|
|
57.49 |
|
|
|
36,324 |
|
|
|
55.03 |
|
|
$60.01–$70.00 |
|
|
1,470,547 |
|
|
|
68.06 |
|
|
|
240,000 |
|
|
|
65.08 |
|
|
$70.01–$80.00 |
|
|
403,783 |
|
|
|
73.07 |
|
|
|
— |
|
|
|
— |
|
|
Total |
|
|
10,585,172 |
|
|
$ |
53.21 |
|
|
|
2,541,397 |
|
|
$ |
42.79 |
|
|
| Summary of Weighted Average Valuation Inputs |
A summary of the weighted average valuation inputs described above used for estimating the grant-date fair value of stock-settled stock appreciation rights awards granted in the periods indicated is as follows:
|
|
|
Year ended December 31, |
|
|
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
Expected term |
|
4.2 years |
|
|
4.1 years |
|
|
3.7 years |
|
|
Expected volatility |
|
|
25.8 |
% |
|
|
27.2 |
% |
|
|
28 |
% |
|
Expected dividend yield |
|
|
0.0 |
% |
|
|
0.0 |
% |
|
|
0.0 |
% |
|
Risk-free interest rate |
|
|
1.5 |
% |
|
|
0.7 |
% |
|
|
0.6 |
% |
|
| Effects of Changes in DaVita Inc's Ownership Interest on Company's Equity |
The effects of changes in DaVita HealthCare Partners Inc.’s ownership interest on the Company’s equity are as follows:
|
|
|
Year ended December 31, |
|
|
|
|
2014 |
|
|
2013 |
|
|
2012 |
|
|
Net income attributable to DaVita HealthCare Partners Inc. |
|
$ |
723,114 |
|
|
$ |
633,446 |
|
|
$ |
536,017 |
|
|
Increase (decrease) in paid-in capital for sales of
noncontrolling interest |
|
|
355 |
|
|
|
(1,442 |
) |
|
|
1,064 |
|
|
Decrease in paid-in capital for the purchase of a
noncontrolling interest |
|
|
(5,357 |
) |
|
|
(3,119 |
) |
|
|
(20,694 |
) |
|
Net transfer to noncontrolling interests |
|
|
(5,002 |
) |
|
|
(4,561 |
) |
|
|
(19,630 |
) |
|
Change from net income attributable to DaVita
HealthCare Partners Inc. and transfers to
noncontrolling interests |
|
$ |
718,112 |
|
|
$ |
628,885 |
|
|
$ |
516,387 |
|
|